XML 35 R22.htm IDEA: XBRL DOCUMENT v3.3.0.814
Segment Reporting (Tables)
 9 Months Ended
Sep. 30, 2015
Segment Reporting [Abstract]  
Summary of segment information
Segment information is as follows (in thousands):
Balance Sheet Data:
As of September 30, 2015
 
Ligand
 
Captisol
 
Total
Total assets
$
449,388

 
$
72,312

 
$
521,700

 
 
 
 
 
 
 
As of December 31, 2014
 
Ligand
 
Captisol
 
Total
Total assets
$
184,215

 
$
73,814

 
$
258,029

 
 
 
 
 
 
Operating Data:
For the three months ended September 30, 2015
 
Ligand
 
Captisol
 
Total
Net revenues from external customers
$
8,885

 
$
8,816

 
$
17,701

Depreciation and amortization expense
$
(45
)
 
$
(598
)
 
$
(643
)
Operating income
$
2,670

 
$
5,927

 
$
8,597

Interest expense, net
$
(2,930
)
 
$
—

 
$
(2,930
)
Income tax benefit (expense)
$
228,101

 
$
(10,846
)
 
$
217,255

 
 
 
 
 
 
 
For the three months ended September 30, 2014
 
Ligand
 
Captisol
 
Total
Net revenues from external customers
$
6,424

 
$
8,549

 
$
14,973

Depreciation and amortization expense
$
(61
)
 
$
(601
)
 
$
(662
)
Operating (loss) income
$
(1,683
)
 
$
5,215

 
$
3,532

Interest expense, net
$
(1,516
)
 
$
—

 
$
(1,516
)
Income tax expense
$
(115
)
 
$
(9
)
 
$
(124
)
 
 
 
 
 
 
 
For the nine months ended September 30, 2015
 
Ligand
 
Captisol
 
Total
Net revenues from external customers
$
23,092

 
$
27,630

 
$
50,722

Depreciation and amortization expense
$
(148
)
 
$
(1,792
)
 
$
(1,940
)
Operating (loss) income
$
(1,336
)
 
$
17,649

 
$
16,313

Interest expense, net
$
(8,875
)
 
$
—

 
$
(8,875
)
Income tax benefit (expense)
$
227,808

 
$
(10,832
)
 
$
216,976

 
 
 
 
 
 
 
For the nine months ended September 30, 2014
 
Ligand
 
Captisol
 
Total
Net revenues from external customers
$
18,907

 
$
22,632

 
$
41,539

Depreciation and amortization expense
$
(194
)
 
$
(1,804
)
 
$
(1,998
)
Operating (loss) income
$
(2,622
)
 
$
12,611

 
$
9,989

Interest expense, net
$
(1,946
)
 
$
—

 
$
(1,946
)
Income tax expense
$
(123
)
 
$
(8
)
 
$
(131
)